Sanctuary Advisors »

Aurinia Pharmaceuticals shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $966k 57k 16.97

More positions owned by Sanctuary Advisors

NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Sanctuary Advisors

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
Goldman Sachs Group
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Marshall Wace
Geode Capital Management
Renaissance Technologies
D. E. Shaw & Co
Vanguard Portfolio Management
Jacobs Levy Equity Management
Caption Management

View all funds holding Aurinia Pharmaceuticals